Table of Contents
ISRN Endocrinology
Volume 2012 (2012), Article ID 237613, 8 pages
http://dx.doi.org/10.5402/2012/237613
Research Article

Octanoylated Ghrelin Inhibits the Activation of the Palmitic Acid-Induced TLR4/NF- B Signaling Pathway in THP-1 Macrophages

Diabetes Center, 2nd Xiangya Hospital, Institute of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology of Ministry of Education, Central South University, 139 Renmin-Zhong Road, Hunan, Changsha 410011, China

Received 7 October 2012; Accepted 24 October 2012

Academic Editors: J.-B. Corcuff and C. Fürnsinn

Copyright © 2012 S. P. Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Google Scholar · View at Scopus
  2. H. Ghanim, A. Aljada, D. Hofmeyer, T. Syed, P. Mohanty, and P. Dandona, “Circulating mononuclear cells in the obese are in a proinflammatory state,” Circulation, vol. 110, no. 12, pp. 1564–1571, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Wu, S. Ghosh, X. D. Perrard et al., “T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity,” Circulation, vol. 115, no. 8, pp. 1029–1038, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Olefsky and C. K. Glass, “Macrophages, inflammation, and insulin resistance,” Annual Review of Physiology, vol. 72, pp. 219–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Kim, K. A. Tysseling, J. Rice et al., “Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKβ,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 989–994, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Roden, T. B. Price, G. Perseghin et al., “Mechanism of free fatty acid-induced insulin resistance in humans,” Journal of Clinical Investigation, vol. 97, no. 12, pp. 2859–2865, 1996. View at Google Scholar · View at Scopus
  7. S. E. Shoelson, J. Lee, and M. Yuan, “Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance,” International Journal of Obesity, vol. 27, supplement 3, pp. S49–S52, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. G. S. Hotamisligil, “Inflammatory pathways and insulin action,” International Journal of Obesity, vol. 27, supplement 3, pp. S53–S55, 2003. View at Publisher · View at Google Scholar
  9. D. Cai, M. Yuan, D. F. Frantz et al., “Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB,” Nature Medicine, vol. 11, no. 2, pp. 183–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Kim, M. Pham, I. Luttrell et al., “Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity,” Circulation Research, vol. 100, no. 11, pp. 1589–1596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Google Scholar · View at Scopus
  14. J. Y. Lee, K. H. Sohn, S. H. Rhee, and D. Hwang, “Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4,” Journal of Biological Chemistry, vol. 276, no. 20, pp. 16683–16689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Suganami, K. Tanimoto-Koyama, J. Nishida et al., “Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 84–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Schäffler and J. Schölmerich, “Innate immunity and adipose tissue biology,” Trends in Immunology, vol. 31, no. 6, pp. 228–235, 2010. View at Publisher · View at Google Scholar
  17. T. Waseem, M. Duxbury, H. Ito, S. W. Ashley, and M. K. Robinson, “Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways,” Surgery, vol. 143, no. 3, pp. 334–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. V. D. Dixit, E. M. Schaffer, R. S. Pyle et al., “Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells,” Journal of Clinical Investigation, vol. 114, no. 1, pp. 57–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. W. G. Li, D. Gavrila, X. Liu et al., “Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells,” Circulation, vol. 109, no. 18, pp. 2221–2226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Kheradmand, M. Alirezaei, and M. Birjandi, “Ghrelin promotes antioxidant enzyme activity and reduces lipid peroxidation in the rat ovary,” Regulatory Peptides, vol. 162, no. 1–3, pp. 84–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Liu, H. Xu, H. Jiang, J. Wang, N. Song, and J. Xie, “Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-κB modulation in MES23.5 cells,” Experimental Neurology, vol. 222, no. 1, pp. 25–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Imazu, S. Yanagi, K. Miyoshi et al., “Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation,” European Journal of Pharmacology, vol. 672, no. 1–3, pp. 153–158, 2011. View at Publisher · View at Google Scholar
  23. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Google Scholar · View at Scopus
  24. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Reyna, S. Ghosh, P. Tantiwong et al., “Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects,” Diabetes, vol. 57, no. 10, pp. 2595–2602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Broglio, C. Gottero, E. Arvat, and E. Ghigo, “Endocrine and non-endocrine actions of ghrelin,” Hormone Research, vol. 59, no. 3, pp. 109–117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Soares and A. F. Leite-Moreira, “Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle,” Peptides, vol. 29, no. 7, pp. 1255–1270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Moazed, D. Quest, and V. Gopalakrishnan, “Des-acyl ghrelin fragments evoke endothelium-dependent vasodilatation of rat mesenteric vascular bed via activation of potassium channels,” European Journal of Pharmacology, vol. 604, no. 1–3, pp. 79–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. G. G. Zhang, X. Teng, Y. Liu et al., “Inhibition of endoplasm reticulum stress by ghrelin protects against ischemia/reperfusion injury in rat heart,” Peptides, vol. 30, no. 6, pp. 1109–1116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. Pöykkö, E. Kellokoski, S. Hörkkö, H. Kauma, Y. A. Kesäniemi, and O. Ukkola, “Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes,” Diabetes, vol. 52, no. 10, pp. 2546–2553, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. O. Ukkola, S. M. Pöykkö, and Y. Antero Kesäniemi, “Low plasma ghrelin concentration is an indicator of the metabolic syndrome,” Annals of Medicine, vol. 38, no. 4, pp. 274–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Z. H. Sung, N. F. Da Silva, S. J. Goodyear, P. G. McTernan, R. P. Arasaradnam, and C. U. Nwokolo, “Ghrelin promotes nuclear factor κ-B activation in a human B-lymphocyte cell line,” Molecular Biology Reports, vol. 38, no. 8, pp. 4833–4838, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Yao, Y. Xiao, S. P. Liu, A. M. Xu, and Z. G. Zhou, “Serum of obesity induce the activation of TLR4/NF-κB signaling pathway on THP-1 cell line,” Zhonghua Yi Xue Za Zhi, vol. 90, no. 44, pp. 3119–3123, 2010. View at Google Scholar
  34. C. B. Newgard, J. An, J. R. Bain et al., “A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance,” Cell Metabolism, vol. 9, no. 4, pp. 311–326, 2009. View at Publisher · View at Google Scholar · View at Scopus